2008
DOI: 10.1111/j.1651-2227.2008.00750.x
|View full text |Cite
|
Sign up to set email alerts
|

Adiponectin: an intriguing hormone for paediatricians

Abstract: Adiponectin, a protein hormone produced by adipocytes, is also found in breast milk, which in turn is implicated in childhood obesity prevention. Although a biological role for adiponectin has not been firmly established, clinical and experimental research indicates that it regulates lipid and glucose metabolism, affects foetal development, and exerts anti-inflammatory and antiatherogenic effects.Conclusion: This review demonstrates an emerging interest of paediatric research on adiponectin. A better understan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
28
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(29 citation statements)
references
References 56 publications
1
28
0
Order By: Relevance
“…This model reveals a significant interaction between trunk adiposity index and adiponectin in the variation of average visfatin concentration. Currently, it is recognized that adiponectin concentrations are inversely proportional to body fat [45,46]. A possible explanation for this interaction may be attributed to reduction of adiponectin levels by increasing trunk fat in obese children, causing the variation of visfatin concentrations.…”
Section: Discussionmentioning
confidence: 99%
“…This model reveals a significant interaction between trunk adiposity index and adiponectin in the variation of average visfatin concentration. Currently, it is recognized that adiponectin concentrations are inversely proportional to body fat [45,46]. A possible explanation for this interaction may be attributed to reduction of adiponectin levels by increasing trunk fat in obese children, causing the variation of visfatin concentrations.…”
Section: Discussionmentioning
confidence: 99%
“…In general, lower infant weights and leaner body compositions are associated with higher levels of adiponectin, at least through the first six months of life (Newburg et al 2010; but see Woo et al 2012). The fact that of adiponectin levels in breast milk can fluctuate with maternal energy balance and also in response to preterm or underweight infants suggests that it plays a key role in mediating the adaptive responses of infant adipose tissues (Savino et al 2008(Savino et al , 2010aWoo et al 2009). Adiponectin levels also correlate with linear growth, perhaps because adiponectin activates osteoblasts (Oshima et al 2005).…”
Section: Adiponectinmentioning
confidence: 99%
“…Adiponectin increases fatty acid oxidation in adipose tissue, liver and muscle, enhancing insulin sensitivity, and inhibits inflammatory mediators and the expression of adhesion molecules within the vascular wall, lowering atherogenic risk (1,16). Adiponectin receptors have been identified predominantly in muscle (AdipoR1) and liver cells (AdipoR2), although in humans they are expressed ubiquitously in the body and brain (2,14,17). In most studies, circulating levels of leptin and adiponectin have been determined by enzyme-linked immunosorbent assays or enzyme immunoassay, or, alternatively, by radioimmunoassay (associated or not with in-house techniques).…”
Section: Leptin and Adiponectinmentioning
confidence: 99%